Evidence map›Paper›PMID 38497492›Full record

ReviewAutophagy2024

Emerging dimensions of autophagy in melanoma.

Christian Pangilinan, Daniel J Klionsky, Chengyu Liang

Abstract readReview
In one paragraph

Review in Autophagy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Autophagy in Melanoma: Molecular Mechanisms and Therapeutic Perspectives.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. PSD3 links autophagic flux to MHC-I-associated immune modulation in esophageal squamous cell carcinoma.Apoptosis : an international journal on programmed cell death · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cell Death Modalities in Therapy of Melanoma.International journal of molecular sciences · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christian PangilinanMolecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.
Daniel J KlionskyLife Sciences Institute, University of Michigan, Ann Arbor, MI, USA.
Chengyu LiangMolecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.

Funding

Targeting exosomal PDL1 to improve immunotherapyP50CA261608 · NCI · WISTAR INSTITUTE · PI HERLYN, MEENHARD F · 2021 to 2025
$11.3M
The mechanism and regulation of autophagyR35GM131919 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DANIEL J. KLIONSKY · 2019 to 2026
$6.4M
Role of UVRAG-mediated Autophagy in Tumor SuppressionR01CA140964 · NCI · WISTAR INSTITUTE · PI LIANG, CHENGYU · 2009 to 2025
$5.4M
Transcriptional Reprogramming in Melanoma PlasticityR01CA289624 · NCI · WISTAR INSTITUTE · PI Chengyu Liang · 2024 to 2026
$3.0M
Molecular Mechanism of UV Protection in Cutaneous MelanomaR01ES029092 · NIEHS · WISTAR INSTITUTE · PI LIANG, CHENGYU · 2019 to 2023
$3.0M
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRCR01CA238457 · NCI · WISTAR INSTITUTE · PI LIANG, CHENGYU · 2020 to 2024
$2.9M
New control of oncogene activation in T-cell leukemiaR01CA262631 · NCI · WISTAR INSTITUTE · PI Chengyu Liang · 2022 to 2026
$2.6M
NCI NIH HHS P50 CA261608NCI NIH HHS R01 CA140964NCI NIH HHS R01 CA238457NCI NIH HHS R01 CA262631NCI NIH HHS R01 CA289624NIEHS NIH HHS R01 ES029092NIGMS NIH HHS R35 GM131919
6 · The paper itself

Abstract

Macroautophagy/autophagy has previously been regarded as simply a way for cells to deal with nutrient emergency. But explosive work in the last 15 years has given increasingly new knowledge to our understanding of this process. Many of the functions of autophagy that are unveiled from recent studies, however, cannot be reconciled with this conventional view of cell survival but, instead, point to autophagy being integrally involved at a deeper level of cell biology, playing a critical role in maintaining homeostasis and promoting an integrated stress/immune response. The new appreciation of the role of autophagy in the evolutionary trajectory of cancer and cancer interaction with the immune system provides a mechanistic framework for understanding the clinical benefits of autophagy-based therapies. Here, we examine current knowledge of the mechanisms and functions of autophagy in highly plastic and aggressive melanoma as a model disease of human malignancy, while highlighting emerging dimensions indicating that autophagy is at play beyond its classical face.

Indexed as

AutophagyMelanomaProto-Oncogene MasAnimalsHumansMAS1 protein, humanProto-Oncogene MasAutophagyhomeostasisimmunotherapymelanomatargeted therapytumor microenvironment

Identifiers

PMID38497492
PMCPMC11262229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.